These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 15726258)
1. Improvement of cardiovascular autonomic dysfunction following anti-copper therapy in Wilson's disease. Deguchi K; Sasaki I; Touge T; Tsukaguchi M; Ikeda K; Shimamura M; Urai Y; Watanabe S; Takeuchi H; Kuriyama S J Neurol; 2005 Apr; 252(4):495-7. PubMed ID: 15726258 [No Abstract] [Full Text] [Related]
2. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism. Purchase R Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435 [TBL] [Abstract][Full Text] [Related]
3. Wilson's disease with cognitive impairment and without extrapyramidal signs: improvement of neuropsychological performance and reduction of MRI abnormalities with trientine treatment. Chung EJ; Kim EG; Kim SJ; Ji KH; Seo JH Neurocase; 2016; 22(1):40-4. PubMed ID: 25988284 [TBL] [Abstract][Full Text] [Related]
5. Clinical considerations for an effective medical therapy in Wilson's disease. Weiss KH; Stremmel W Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532 [TBL] [Abstract][Full Text] [Related]
6. Trientine-induced neurological deterioration in a patient with Wilson's disease. Kim B; Chung SJ; Shin HW J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038 [TBL] [Abstract][Full Text] [Related]
8. A copper for your thoughts. Coates RA J Insur Med; 2012; 43(2):112-5. PubMed ID: 22876415 [No Abstract] [Full Text] [Related]
9. [Pregnancy in a patient treated with trientine dihydrochloride for Wilson's disease]. Desbriere R; Roquelaure B; Sarles J; Boubli L Presse Med; 1998 May 2-9; 27(17):806. PubMed ID: 9767885 [No Abstract] [Full Text] [Related]
10. Current Drug Managements of Wilson's Disease: From West to East. Li WJ; Chen C; You ZF; Yang RM; Wang XP Curr Neuropharmacol; 2016; 14(4):322-5. PubMed ID: 26639459 [TBL] [Abstract][Full Text] [Related]
11. Dense Kayser-Fleischer ring in asymptomatic Wilson's disease (hepatolenticular degeneration). Sullivan CA; Chopdar A; Shun-Shin GA Br J Ophthalmol; 2002 Jan; 86(1):114. PubMed ID: 11801516 [No Abstract] [Full Text] [Related]
12. Chelating polymeric beads as potential therapeutics for Wilson's disease. Mattová J; Poučková P; Kučka J; Skodová M; Vetrík M; Stěpánek P; Urbánek P; Petřík M; Nový Z; Hrubý M Eur J Pharm Sci; 2014 Oct; 62():1-7. PubMed ID: 24815561 [TBL] [Abstract][Full Text] [Related]
13. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations. Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347 [TBL] [Abstract][Full Text] [Related]
14. Extending the mode of action of triethylenetetramine (trientine): Autophagy besides copper chelation. Pietrocola F; Castoldi F; Zischka H; Kroemer G J Hepatol; 2020 Oct; 73(4):970-972. PubMed ID: 32684364 [No Abstract] [Full Text] [Related]
15. Diagnosis and treatment of presymptomatic Wilson's disease. Walshe JM Lancet; 1988 Aug; 2(8608):435-7. PubMed ID: 2900362 [TBL] [Abstract][Full Text] [Related]
16. Effect of treatment of Wilson's disease on natural history of haemochromatosis. Walshe JM; Cox DW Lancet; 1998 Jul; 352(9122):112-3. PubMed ID: 9672279 [No Abstract] [Full Text] [Related]
17. The link between copper and Wilson's disease. Purchase R Sci Prog; 2013; 96(Pt 3):213-23. PubMed ID: 24244969 [TBL] [Abstract][Full Text] [Related]
18. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation? Schilsky ML Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695 [TBL] [Abstract][Full Text] [Related]